JOHN BELMONT to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications JOHN BELMONT has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.178
-
Lipocalin 2 is required for BCR-ABL-induced tumorigenesis. Oncogene. 2008 Oct 16; 27(47):6110-9.
Score: 0.074
-
Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia. Oncogene. 2005 May 05; 24(20):3246-56.
Score: 0.059
-
BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model. Oncogene. 2001 Apr 05; 20(15):1873-81.
Score: 0.045